Examples of using Hyperkalaemia in English and their translations into Croatian
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
diabetes mellitus, hyperkalaemia, infections, hypertension and insomnia.
If an elevated(or rising) serum potassium level is detected then consideration should be given to ceasing erythropoietin administration until hyperkalaemia has been corrected.
diabetes mellitus, hyperkalaemia, infections, hypertension and insomnia.
an increased incidence of hyperkalaemia was not observed in clinical trials performed in dogs with this combination.
patients with other co-morbidities, the risk of hyperkalaemia, which may be fatal, is increased.
is dizziness, hyperkalaemia high blood potassium levels.
The most commonly reported adverse reactions during treatment with Entresto were hypotension, hyperkalaemia and renal impairment see section 4.4.
However, in dogs with renal impairment regular monitoring of renal function and serum potassium levels is recommended as there may be an increased risk of hyperkalaemia.
aliskiren increases the risk of hypotension, hyperkalaemia and decreased renal function including acute renal failure.
arthralgia(joint pain) and hyperkalaemia high blood potassium levels.
The risk of hyperkalaemia appears to be greater during longer treatment, but hyperkalaemia is usually reversible.
It is therefore recommended to monitor plasma potassium levels when using FORTEKOR PLUS in combination with a potassium sparing diuretic because of the risk of hyperkalaemia.
especially in dogs which may suffer hypoadrenocorticism, hyperkalaemia or hyponatraemia.
for the treatment of hyperkalaemia.
Hyperkalaemia, hyponatremia or Na⁺/K⁺ ratio<
Conversely, due to the antagonism of the angiotensin II(AT1) receptors by the telmisartan component of Actelsar HCT, hyperkalaemia might occur.
Combination of Entresto with aliskiren is potentially associated with a higher frequency of adverse events such as hypotension, hyperkalaemia and decreased renal function(including acute renal failure) see sections 4.3 and 4.4.
Hypotension, syncope, stroke, hyperkalaemia, and decreased renal function(including acute renal failure)
hypotension, hyperkalaemia) see section 5.3.
chronic renal insufficiency and overt proteinuria, hyperkalaemia(≥ 5.5 mEq/L)